N-[(6-methyl-2-piperidin-1-ylpyrimidin-4-yl)methyl]-11-oxo-1-azatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-triene-6-sulfonamide
C22H27N5O3S — CID 122352981
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(6-methyl-2-piperidin-1-ylpyrimidin-4-yl)methyl]-11-oxo-1-azatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-triene-6-sulfonamide
N-[(6-methyl-2-piperidin-1-ylpyrimidin-4-yl)methyl]-11-oxo-1-azatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-triene-6-sulfonamide (PubChem CID 122352981) has the molecular formula C22H27N5O3S and a molecular weight of 441.56 g/mol. Its IUPAC name is N-[(6-methyl-2-piperidin-1-ylpyrimidin-4-yl)methyl]-11-oxo-1-azatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-triene-6-sulfonamide.
Molecular Properties
| Compound Name | N-[(6-methyl-2-piperidin-1-ylpyrimidin-4-yl)methyl]-11-oxo-1-azatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-triene-6-sulfonamide |
|---|---|
| PubChem CID | 122352981 |
| Molecular Formula | C22H27N5O3S |
| Molecular Weight | 441.56 g/mol |
| Exact Mass | 441.18 |
| IUPAC Name | N-[(6-methyl-2-piperidin-1-ylpyrimidin-4-yl)methyl]-11-oxo-1-azatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-triene-6-sulfonamide |
| SMILES | Cc1cc(CNS(=O)(=O)c2cc3c4c(c2)CCN4C(=O)CC3)nc(N2CCCCC2)n1 |
| InChI | InChI=1S/C22H27N5O3S/c1-15-11-18(25-22(24-15)26-8-3-2-4-9-26)14-23-31(29,30)19-12-16-5-6-20(28)27-10-7-17(13-19)21(16)27/h11-13,23H,2-10,14H2,1H3 |
| InChIKey | OQLYWCZQRBQCPS-UHFFFAOYSA-N |
| XLogP | 2.09 |
| TPSA | 95.50 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 441.56 |
| LogP ≤ 5 | 2.09 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122352981 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.